Literature DB >> 24339625

Racemose neurocysticercosis and reversible dementia.

Somsri Wiwanitkit1, Viroj Wiwanitkit.   

Abstract

Entities:  

Year:  2013        PMID: 24339625      PMCID: PMC3841646          DOI: 10.4103/0972-2327.120434

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, The recent publication on racemose neurocysticercosis (NCC) and reversible dementia is very interesting.[1] Sharma et al. reported that “The outcome of dementia patients with NCC seems favorable in most cases; therefore, a high index of suspicion for NCC should be kept, especially in endemic areas.”[1] Indeed, the neurological symptom is not rate in NCC. Indeed, the existing of dementia and cognitive function impairment in NCC is more common in non-calcified active NCC.[2] Nearly, 40% of all non-calcified active NCC can present with dementia. In the real life, dementia might be lately detected and clinical work-up does usually not include looking for NCC. Focusing on the outcome; although, the present report showed favorable outcome.[1] Some previous reports mentioned for discordant observation after complete treatment.[3]
  3 in total

1.  Spectrum of cognitive impairment in neurocysticercosis: differences according to disease phase.

Authors:  C L Rodrigues; D C de Andrade; J A Livramento; L R Machado; R Abraham; L Massaroppe; L T Lucato; P Caramelli
Journal:  Neurology       Date:  2012-03-07       Impact factor: 9.910

2.  Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study.

Authors:  D Ciampi de Andrade; C L Rodrigues; R Abraham; L H M Castro; J A Livramento; L R Machado; C C Leite; P Caramelli
Journal:  Neurology       Date:  2010-04-20       Impact factor: 9.910

3.  Reversible dementia as a presenting manifestation of racemose neurocysticercosis.

Authors:  Sudhir Sharma; Manish Modi; Vivek Lal; Sudesh Prabhakar; Amit Bhardwaj; Rakesh Sehgal
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

  3 in total
  2 in total

1.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

2.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2018-04       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.